Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration

Alzheimer's disease is a chronic degenerative disorder characterized by the intracellular accumulation of "paired helical filaments" consisting of highly phosphorylated tau and by extracellular deposits of aggregated Abeta-peptide. Furthermore, neurodegeneration in Alzheimer's disease is associated with the appearance of neuritic growth profiles that are aberrant with respect to their localization, morphological appearance, and composition of cytoskeletal elements. During early stages of Alzheimer's disease, a variety of growth factors and mitogenic compounds are elevated. Most of these factors mediate their cellular effects through activation of the p21ras-dependent mitogen-activated protein kinase cascade, a pathway that is also involved in the regulation of expression and post-translational modification of the amyloid precursor protein and tau protein. We previously reported on the elevated expression of p21ras associated with paired helical filament formation and Abeta-deposits. However, the question arises as to whether induction of p21ras and the downstream mitogen-activated protein kinase cascade is an early event with rather primary importance in the pathogenetic chain or simply occurs as a cellular response to neurodegeneration. The present study shows that expression of p21ras is clearly elevated in very early stages of the disease, preceding both neurofibrillary pathology and formation of Abeta.

[1]  A. Smith,et al.  Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.

[2]  P. Gluckman,et al.  Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. , 1997, Brain research. Molecular brain research.

[3]  A. Smith,et al.  The cell division cycle and the pathophysiology of Alzheimer's disease. , 1998, Neuroscience.

[4]  A. Smith,et al.  Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.

[5]  E. Sadot,et al.  Ras‐Signaling Pathways: Positive and Negative Regulation of Tau Expression in PC12 Cells , 1998, Journal of neurochemistry.

[6]  T. Arendt,et al.  Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[7]  S. Scott,et al.  Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. , 1996, Brain research. Molecular brain research.

[8]  T. Arendt,et al.  Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease , 1998, Journal of Neural Transmission.

[9]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[10]  V. Ingram,et al.  Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease. , 1994, Biochemical and biophysical research communications.

[11]  M. Viitanen,et al.  Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[12]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[13]  P. Greengard,et al.  Regulation of Secretion of Alzheimer Amyloid Precursor Protein by the Mitogen‐Activated Protein Kinase Cascade , 1998, Journal of neurochemistry.

[14]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[15]  J. Rubin,et al.  Hepatocyte growth factor (HGF/SF) in Alzheimer's disease , 1998, Brain Research.

[16]  E. Mandelkow,et al.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.

[17]  L. Phillips,et al.  Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus , 1994, Neuroscience.

[18]  K. Herrup,et al.  Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.

[19]  H. Yeh,et al.  Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  T. Arendt,et al.  Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease , 1995, The Journal of comparative neurology.

[21]  Á. Pascual,et al.  Nerve Growth Factor and Ras Regulate β‐Amyloid Precursor Protein Gene Expression in PC12 Cells , 1996, Journal of neurochemistry.

[22]  Y. Agid,et al.  Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. , 1985, Brain : a journal of neurology.

[23]  D. Selkoe,et al.  Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Lowy,et al.  Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. , 1984, The EMBO journal.

[25]  Brian J Cummings,et al.  Induction of basic fibroblast growth factor in Alzheimer's disease pathology. , 1990, Neuroreport.

[26]  P. Reiner,et al.  Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway , 1997, The Journal of Neuroscience.

[27]  C. Marshall,et al.  Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein , 1997, Current Biology.

[28]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[29]  T. Arendt,et al.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.

[30]  S. Green,et al.  ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells , 1991, The Journal of cell biology.

[31]  G. Drewes,et al.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.

[32]  R. Heumann,et al.  Induction of p21ras in Alzheimer pathology. , 1995, Neuroreport.